American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxis

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 6, 2007, Pages 1373-1377

  Cox, Linda ^a   Platts Mills, Thomas A E ^b   Finegold, Ira ^c   Schwartz, Lawrence B ^d   Simons, F Estelle R ^e   Wallace, Dana V ^a  

^a Nova Southeastern University   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MANITOBA   (Canada)

Author keywords

anaphylaxis; hypersensitivity; IgE antibody; Omalizumab; recombinant monoclonal antibodies; Xolair

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; CETUXIMAB; CORTICOSTEROID; EXCIPIENT; GLUCOCORTICOID; HISTIDINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MONOCLONAL ANTIBODY; OMALIZUMAB; POLYSORBATE 20; SALBUTAMOL; SUCROSE;

ANAPHYLAXIS; ANTIGEN ANTIBODY REACTION; ARTICLE; HUMAN; HYPERSENSITIVITY REACTION; INCIDENCE; ORGANIZATION; PATIENT EDUCATION; PHYSICIAN; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL;

ACADEMIES AND INSTITUTES; ADVISORY COMMITTEES; ALLERGY AND IMMUNOLOGY; ANAPHYLAXIS; ANTI-ALLERGIC AGENTS; ANTI-ASTHMATIC AGENTS; ANTIBODIES, MONOCLONAL; ASTHMA; HUMANS; UNITED STATES;

EID: 36749096427     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.09.032     Document Type: Article

References (15)

1. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 115 suppl (2005) S483-S523
2. Simons F.E. Anaphylaxis, killer allergy: long-term management in the community. J Allergy Clin Immunol 117 (2006) 367-377
3. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program Expert Panel Report 3: guidelines for the diagnosis and management of asthma (2007), National Heart, Lung, and Blood Institute, Bethesda (MD)
4. Klastersky J. Adverse effects of the humanized antibodies used as cancer therapeutics. Curr Opin Oncol 18 (2006) 316-320
5. Baudouin V., Crusiaux A., Haddad E., Schandene L., Goldman M., Loirat C., et al. Anaphylactic shock caused by immunoglobulin E sensitization after retreatment with the chimeric anti-interleukin-2 receptor monoclonal antibody basiliximab. Transplantation 76 (2003) 459-463
6. Cheifetz A., and Mayer L. Monoclonal antibodies, immunogenicity, and associated infusion reactions. Mt Sinai J Med 72 (2005) 250-256
7. Genentech, Inc. Xolair (omalizumab) [product insert]. South San Francisco; 2007.
8. Cheifetz A., Smedley M., Martin S., Reiter M., Leone G., Mayer L., et al. The incidence and management of infusion reactions to infliximab: a large center experience. Am J Gastroenterol 98 (2003) 1315-1324
9. Leonard P.A., Woodside K.J., Gugliuzza K.K., Sur S., and Daller J.A. Safe administration of a humanized murine antibody after anaphylaxis to a chimeric murine antibody. Transplantation 74 (2002) 1697-1700
10. Kozutsumi D., Tsunematsu M., Yamaji T., Murakami R., Yokoyama M., and Kino K. PS80 interferes with the antiallergic effect of Cry-consensus peptide, a novel recombinant peptide for immunotherapy of Japanese cedar pollinosis, at very low concentration through modulation of Th1/Th2 balance. Immunology 118 (2006) 392-401
11. Steele R.H., Limaye S., Cleland B., Chow J., and Suranyi M.G. Hypersensitivity reactions to the polysorbate contained in recombinant erythropoietin and darbepoietin. Nephrology (Carlton) 10 (2005) 317-320
12. Price K.S., and Hamilton R.G. Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy. Allergy Asthma Proc 28 (2007) 313-319
13. Castells M. Desensitization for drug allergy. Curr Opin Allergy Clin Immunol 6 (2006) 476-481
14. Sampson H.A., Munoz-Furlong A., Campbell R.L., Adkinson Jr. N.F., Bock S.A., Branum A., et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 117 (2006) 391-397
15. Johnson T.L., and Parker A.L. Rates of retrieval of self-injectable epinephrine prescriptions: a descriptive report. Ann Allergy Asthma Immunol 97 (2006) 694-697